3 studies found for: Open Studies | "Hereditary Breast and Ovarian Cancer Syndrome"
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
† Indicates status has not been verified in more than two years